[1]李 靖.非高密度脂蛋白胆固醇与心脑血管疾病的关系研究[J].医学信息,2022,35(12):100-103.[doi:10.3969/j.issn.1006-1959.2022.12.024]
　LI Jing.Study on the Relationship Between Non-high Density Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Diseases[J].Medical Information,2022,35(12):100-103.[doi:10.3969/j.issn.1006-1959.2022.12.024]
点击复制

非高密度脂蛋白胆固醇与心脑血管疾病的关系研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年12期
页码:
100-103
栏目:
综述
出版日期:
2022-06-15

文章信息/Info

Title:
Study on the Relationship Between Non-high Density Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Diseases
文章编号:
1006-1959（2022）12-0100-04
作者:
李 靖
（天津港口医院内科，天津 300456）
Author(s):
LI Jing
(Department of Internal Medicine,Tianjin Port Hospital,Tianjin 300456,China)
关键词:
非高密度脂蛋白胆固醇; 心脑血管疾病; 动脉粥样硬化; 低密度脂蛋白
Keywords:
Non-high density lipoprotein cholesterol; Cardiovascular and cerebrovascular diseases; Atherosclerosis; Low density lipoprotein
分类号:
R54
DOI:
10.3969/j.issn.1006-1959.2022.12.024
文献标志码:
A
摘要:
非高密度脂蛋白胆固醇（non-HDL-C）反映致动脉粥样硬化胆固醇的总量，而动脉粥样硬化是多种心脑血管疾病的基础，会进一步诱发心肌梗死、脑梗死。目前，non-HDL-C在冠状动脉粥样硬化性心脏病发病率、死亡率方面的预测价值已经得到证实，甚至优于传统的血脂指标。但是关于non-HDL-C和心脑血管疾病的相关研究较少，且已有研究存在争议。本文主要对non-HDL-C与心脑血管疾病的关系进行综述，以期为心脑血管疾病的诊治提供参考依据。
Abstract:
Non-high density lipoprotein cholesterol (non-HDL-C) reflects the total amount of atherosclerosis cholesterol, and atherosclerosis is the basis of a variety of cardiovascular and cerebrovascular diseases, which can further induce myocardial infarction and cerebral infarction. At present, the predictive value of non-HDL-C in the incidence and mortality of coronary atherosclerotic heart disease has been confirmed, even better than the traditional blood lipid index. However, there are few studies on non-HDL-C and cardiovascular and cerebrovascular diseases, and the existing studies are controversial. This article reviews the relationship between non-HDL-C and cardiovascular and cerebrovascular diseases, in order to provide reference for the diagnosis and treatment of cardiovascular and cerebrovascular diseases.

参考文献/References:

[1]Sviridov D,Mukhamedova N,Miller YI.Lipid rafts as a therapeutic target[J].J Lipid Res,2020,61(5):687-695.[2]王晓燕,毕洪春,Non-HDL-C和AI对冠心病患者病情的评估价值[J].中国实用医刊,2016,19(43):23-26.[3]陈秀娟,黄智慧.非高密度脂蛋白胆固醇在冠状动脉粥样硬化性心脏病预测及预后评估中的价值[J].中国医学工程,2016,24(7):53-55.[4]张翠婕,张梅.非高密度脂蛋白、同型半胱氨酸、尿酸水平与冠状动脉病变程度的相关性分析[J].吉林医学,2016,37(8):1855-1858.[5]陈思锐,张利华,刘军,等.非高密度脂蛋白胆固醇与急性冠脉综合征患者早期再发主要心血管事件的关系及其临床意义[J].心脏杂志,2016,28(6):704-707.[6]中国成人血脂异常防治指南修定联合委员会.中国成人血脂异常防治指南（2016年修订版）[J]中国循环杂志,2016,31(10):833-853.[7]徐嘉,徐岩,张建华,等.血清载脂蛋白B联合非高密度脂蛋白胆固醇对冠心病的预测价值[J].安徽医科大学学报,2016,51(2):259-262.[8]杨絮,张勇刚.低密度脂蛋白C、非高密度脂蛋白C、动脉硬化指数与冠心病严重程度的相关性分析[J].汕头大学医学院学报,2016,(1):27-29.[9]Marsche G,Heine GH,Stadler JT,et al.Current understanding of the relationship of HDL composition, structure and function to their cardioprotective properties in chronic kidney disease[J].Biomolecules,2020,10(9):1348.[10]薛雅芝,曾晓容,林子祥,等.C反应蛋白高密度脂蛋白胆固醇比值、中性粒细胞淋巴细胞比值对冠心病的预测价值研究[J].中国全科医学,2020,23(25):3194-3199,3206.[11]赵明中,李慧敏,陈慧敏,等.住院老年动脉粥样硬化性心血管疾病患者血脂达标情况分析[J].中华老年心脑血管病杂志,2016,18(3):229-232.[12]张娜娜,冯燕娴.非高密度脂蛋白胆固醇在评估血糖升高的冠心病患者中的应用价值[J].东南大学学报(医学版),2017,36(1):70-73.[13]Du T,Sun X,Yu X.Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease[J].Lipids in Health and Disease,2017,16(1):229.[14]孙佳艺,赵冬,刘静,等.中国缺血性脑卒中住院患者颈动脉粥样硬化病变性别差异的分析[J].心肺血管病杂志,2016,35(2):81-86.[15]王赛华,赵志宏,罗俊,等.H型高血压病人合并急性脑梗死与颈动脉粥样硬化的相关性[J].中西医结合心脑血管病杂志,2016,14(17):1984-1986.[16]吴婉玉,廖峻,黄劼,等.急性前循环脑梗死患者血压变异性与颈动脉粥样硬化斑块的相关性[J].西部医学,2017,29(6):795-798.[17]Anderson TJ,Grégoire J,Pearson GJ,et al.2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult[J].Canadian Journal of Cardiology.2016,32(11):1263-1282.[18]李德义,罗莉,熊萍,等.颈动脉粥样硬化患者发生脑卒中的危险因素[J].医学综述,2016,22(19):3890-3892.[19]曾素芬.载脂蛋白E基因多态性与不同性别和病因分型的脑梗死患者的关系研究[J].疾病监测与控制,2018,12(1):28-30.[20]兰翠霞,李惠勉,贾贺,等.ApoE基因多态性对老年脑梗死患者颅内血管狭窄病理变化的影响[J].中国老年学杂志,2017,37(12):2918-2920.[21]Zhang Y,Wu NQ,Li S,et al.Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C[J].Heart, Lung and Circulation,2016,25(10):975-981.[22]凌启节.血清LP(a)、ApoE水平与大动脉粥样硬化型脑梗死的关系[J].皖南医学院学报,2017,36(6):552-554.[23]于雪莹,王娜,李江,等.载脂蛋白E基因多态性与2型糖尿病患者发生脑梗死的相关性研究[J].中华检验医学杂志,2020,43(2):160-164.[24]王炎强,孙绍洋,张炳俊,等.大动脉粥样硬化性首发急性缺血性卒中的危险因素与分布特点[J].中国神经精神疾病杂志,2016,42(4):222-227.[25]Gurbel PA,Tantry US,D’Andrea D,et al.Evaluation of potential antiplatelet effects of CSL112(Apolipoprotein A-I[Human])in patients with atherosclerosis:results from a phase 2a study[J].J Thromb Thrombolysis,2018,45(4):469-476.[26]李美珠,李炜煊,梁指荣,等.非高密度脂蛋白胆固醇对氧化应激的影响及其与脑卒中的相关性研究[J].海南医学,2016,27(1):25-27.[27]刘秦,方勇涛,李少明.非高密度脂蛋白胆固醇水平对动脉硬化性脑梗死患者预后的影响[J].卒中与神经疾病,2017,24(4):342-344.[28]陈阳,彭朝权.阿托伐他汀和瑞舒伐他汀强化治疗方案控制冠状动脉粥样硬化进展的疗效及安全性[J].循证医学,2015,15(6):342-347.[29]Ahn N,Kim K.High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease:effect of exercise training[J].Integrative Medicine Research,2016,5(3):212-215.[30]姚朝阳,田华伟,梁爱敏.高密度脂蛋白胆固醇与冠状动脉狭窄程度的相关性研究[J].中国循证心血管医学杂志,2018,10(1):91-94.

相似文献/References:

[1]马娟娟.心脑血管疾病主要危险因素及综合防控的研究[J].医学信息,2020,33(11):49.[doi:10.3969/j.issn.1006-1959.2020.11.016]
　MA Juan-juan.Study on the Main Risk Factors and Comprehensive Prevention and Control of Cardiovascular and Cerebrovascular Diseases[J].Medical Information,2020,33(12):49.[doi:10.3969/j.issn.1006-1959.2020.11.016]
[2]王 辉,柳光斌,王现玲,等.2016年~2019年天津市南开区心脑血管疾病发病和死亡变化分析[J].医学信息,2021,34(05):143.[doi:10.3969/j.issn.1006-1959.2021.05.041]
　WANG Hui,LIU Guang-bin,WANG Xian-ling,et al.Analysis of Changes in the Incidence and Death of Cardiovascular and Cerebrovascular Diseases in Nankai District,Tianjin from 2016 to 2019[J].Medical Information,2021,34(12):143.[doi:10.3969/j.issn.1006-1959.2021.05.041]
[3]来佳成,韩永生.脂蛋白磷脂酶A2、非高密度胆固醇与颈动脉粥样硬化程度的相关性研究[J].医学信息,2021,34(09):115.[doi:10.3969/j.issn.1006-1959.2021.09.030]
　LAI Jia-cheng,HAN Yong-sheng.Study on the Correlation Between Lipoprotein Phospholipase A2,Non-high-density Cholesterol and the Degree of Carotid Atherosclerosis[J].Medical Information,2021,34(12):115.[doi:10.3969/j.issn.1006-1959.2021.09.030]
[4]丛革新,贾 鑫,刘 辉.2009年~2019年天津市河北区居民心脑血管疾病死亡趋势分析[J].医学信息,2021,34(13):156.[doi:10.3969/j.issn.1006-1959.2021.13.043]
　CONG Ge-xin,JIA Xin,LIU Hui.Analysis of Death Trend of Cardiovascular and Cerebrovascular Diseases Among Residents in Hebei District of Tianjin from 2009 to 2019[J].Medical Information,2021,34(12):156.[doi:10.3969/j.issn.1006-1959.2021.13.043]
[5]李 华.2010年~2019年广西某医院住院患者死亡病例分析[J].医学信息,2021,34(13):149.[doi:10.3969/j.issn.1006-1959.2021.13.041]
　LI Hua.Analysis of Death Cases of Inpatients in a Hospital in Guangxi from 2010 to 2019[J].Medical Information,2021,34(12):149.[doi:10.3969/j.issn.1006-1959.2021.13.041]
[6]赵 一.2015年~2019年朝阳市喀左县心脑血管疾病死亡流行特征及变化趋势[J].医学信息,2021,34(15):149.[doi:10.3969/j.issn.1006-1959.2021.15.041]
　ZHAO Yi.Epidemiological Characteristics and Trend of Death from Cardiovascular and Cerebrovascular Diseases in Kazuo County,Chaoyang City from 2015 to 2019[J].Medical Information,2021,34(12):149.[doi:10.3969/j.issn.1006-1959.2021.15.041]
[7]许凤姣.凝血功能检验在心脑血管疾病患者预后评估中的价值[J].医学信息,2023,36(11):138.[doi:10.3969/j.issn.1006-1959.2023.11.028]
　XU Feng-jiao.Value of Coagulation Function Test in the Prognosis Evaluation of Patients with Cardiovascular and Cerebrovascular Diseases[J].Medical Information,2023,36(12):138.[doi:10.3969/j.issn.1006-1959.2023.11.028]

更新日期/Last Update: 1900-01-01